AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Scagnelli, M Pellizer, G de Lalla, F D'Emilio, A Rassu, M Bragagnolo, L Reatto, P Veneri, G Ligozzi, M Fontana, R
Citation: M. Scagnelli et al., Epidemiological analysis of vancomycin-resistant enterococci in a large tertiary-care hospital in northern Italy, EUR J CL M, 20(9), 2001, pp. 609-616

Authors: Pellizzer, G Strazzabosco, M Presi, S Furlan, F Lora, L Benedetti, P Bonato, M Erle, G de Lalla, F
Citation: G. Pellizzer et al., Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection, DIABET MED, 18(10), 2001, pp. 822-827

Authors: Benedetti, P de Lalla, F
Citation: P. Benedetti et F. De Lalla, Antibiotic therapy in acute renal failure, CONTR NEPHR, 132, 2001, pp. 136-145

Authors: de Lalla, F Pellizzer, G Strazzabosco, M Martini, Z Du Jardin, G Lora, L Fabris, P Benedetti, P Erle, G
Citation: F. De Lalla et al., Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic footinfection, ANTIM AG CH, 45(4), 2001, pp. 1094-1098

Authors: Fabris, P Dalla Palma, M de Lalla, F
Citation: P. Fabris et al., Idiosyncratic acute hepatitis caused by paracetamol in two patients with melanoma treated with high-dose interferon-alpha, ANN INT MED, 134(4), 2001, pp. 345-345

Authors: de Lalla, F
Citation: F. De Lalla, Oral cephalosporins in airway infections, CL MICRO IN, 6, 2000, pp. 70-72

Authors: de Lalla, F Nicolin, R Lazzarini, L
Citation: F. De Lalla et al., Safety and efficacy of recombinant granulocyte colony-stimulating factor as an adjunctive therapy for Streptococcus pneumoniae meningitis in non-neutropenic adult patients: a pilot study, J ANTIMICRO, 46(5), 2000, pp. 843-846

Authors: Fabris, P Biasin, MR Infantolino, D Tositti, G Venza, E Floreani, A Zanetti, A de Lalla, F
Citation: P. Fabris et al., TTV infection in patients with acute hepatitis of defined aetiology and inacute non-A-E hepatitis, J HEPATOL, 32(4), 2000, pp. 661-665

Authors: Betterle, C Fabris, P Zanchetta, R Pedini, B Tositti, G Bosi, E de Lalla, F
Citation: C. Betterle et al., Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection, DIABET CARE, 23(8), 2000, pp. 1177-1181

Authors: de Lalla, F Viola, R Pellizzer, G Lazzarini, L Tramarin, A Fabris, P
Citation: F. De Lalla et al., Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: an open study, ANTIM AG CH, 44(2), 2000, pp. 316-319

Authors: Fabris, P Marranconi, F Bozzola, L Biasin, MR De Lazzari, F Plebani, M Benedetti, P Tositti, G Pellizzer, G Stecca, C de Lalla, F
Citation: P. Fabris et al., Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFN, J GASTRO, 34(3), 1999, pp. 345-350

Authors: Fabris, P Infantolino, D Biasin, MR Marchelle, G Venza, E Marin, VTW Benedetti, P Tositti, G Manfrin, V de Lalla, F
Citation: P. Fabris et al., High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no evidence of HCV transmission among sexual partners, INFECTION, 27(2), 1999, pp. 86-91

Authors: Fabris, P Tositti, G Mazzella, G Zanetti, AR Nicolin, R Pellizzer, G Benedetti, P de Lalla, F
Citation: P. Fabris et al., Effect of ursodeoxycholic acid administration in patients with acute viralhepatitis: a pilot study, ALIM PHARM, 13(9), 1999, pp. 1187-1193

Authors: Fabris, P Manfrin, V Rassu, M Tositti, G de Lalla, F Zanetti, A
Citation: P. Fabris et al., Triple therapy prevents HIV but not HCV transmission after needlestick injury, AM J GASTRO, 94(7), 1999, pp. 1990-1991

Authors: Tositti, G Fabris, P de Lalla, F
Citation: G. Tositti et al., Incidence, risk factors, and clinical significance of neurological symptoms in adult patients with acute gastroenteritis, AM J GASTRO, 94(10), 1999, pp. 3078-3079
Risultati: 1-15 |